Francisella
Related VFcategory: Regulation
Target: QseC
Drug effect: Decreases biofilm formation in vitro by disrupting QseC-dependent tow-component system signaling.
Max phase: Preclinical (in vivo)
Publication: Dean SN, et al., 2015. Screen of FDA-approved drug library identifies maprotiline, an antibiofilm and antivirulence compound with QseC sensor-kinase dependent activity in Francisella novicida. Virulence 6(5):487-503.